Cleansing Natural Surfactant -

Demonstrate that Rhamnolipids are effective as primary surfactant in cleansing formulations such as shampoos, conditioners, body wash and hand soaps. Also, the study will include formulations/ blends, benefits, and properties of rhamnolipids - foam profile, skin mildness, viscosity of final formulation, and their benchmarking with SLES/Betaine, etc.

Skin Care Emulsifier -

Demonstrate that Rhamnolipids are effective as emulsifier for formulation or lotion base of readily spreadable w/o and o/w emulsions able to displace silicone emulsifiers. Also, the study will include properties of rhamnolipids - spreadability, emulsification, emulsion stability, skin sensory feel, viscosity profile and their benchmarking with silicones, e.g. D5 cyclomethicone.

Skin Care Anti-aging -

Demonstrate that Rhamnolipids are effective for the treatment of wrinkles, age-spots, and other visual/consumer-perceptible signs of aging. Also, the study will include benefits demonstrated by gene expression for improved collagen and elastin gene expression, and improved consumer-perceptible anti-aging benefits as compared to market-leading benchmarks.

Skin Care Reduction of Redness -

Demonstrate that Rhamnolipids are effective for the treatment/prevention of skin irritation/redness. Parity or superior to commercially available anti-irritants such as Squalane and/or other benchmarks. Synergy with squalane and/or other benchmarks as a boost in efficacy

Skin Care Microbiome -

Demonstrate that Rhamnolipids are effective for the beneficial balance of skin microbiome. The ‘Shannon Index’ is considered a valid parameter which indicates the diversity and distribution of the different species. For each skin region with an individual microbiome, the following applies – the higher the Shannon Index, the more natural and healthier the skin flora.

Skin Care Reduction of Acne -

Demonstrate that Rhamnolipids are effective for the reduction, treatment, or prevention of acne. Benchmarks: salicylic acid and benzoyl peroxide; Superior or parity performance of reduction of microorganisms responsible for acne; Superior or parity performance of reduction of redness and microscopic images of skin.

Skin Care Wound Care -

Demonstrate that Rhamnolipids are effective for the treatment/acceleration of wound healing. Identifying efficacy and perform benchmarks – aloe, etc.

Skin Care Antifungal -

Demonstrate that Rhamnolipids are effective for the treatment/prevention of foot fungus. Screen against industry benchmark ingredients.

Skin Care Flavor Emulsifier -

Demonstrate that Rhamnolipids are effective emulsifiers for flavors relevant to oral care toothpastes and mouthwashes. Demonstrate effective emulsification vs. industry benchmark of poloxamer 407; Cinnamon oil (0.2%), Poloxamer 407 benchmark (0.3%); Peppermint oil (0.2%) Poloxamer 407 benchmark (0.5%).

Skin Care Natural Surfactant -

Demonstrate that Rhamnolipids are effective co-surfactants for natural oral care toothpastes. Demonstrate effective foaming vs. industry benchmark of SLS; Provide better foaming and taste profile than APG’s; Provide emulsification benefit for flavor oils in formulation.

Skin Care Antiseptic -

Demonstrate that Rhamnolipids are effective for the treatment/prevention of biofilm formation for oral care relevant bacteria. Also, including Anti-plaque, Anti-gingivitis, reducing bad breath. Natural alternative (rhamnolipid) with equivalent to superior performance vs. Industry benchmarks (CPC, essential oils)

Skin Care Anti-Dandruff -

Demonstrate that Rhamnolipids are effective for the treatment/prevention of dandruff. Stand alone antidandruff active: parity or superior to ZPTO; Stabilizing ingredient for ZPTO, Selenium sulfide; Synergy with ZPTO. Also, the study will include viscosity and foam profiles and stability.

Skin Care Contact Lens Surfactant -

Demonstrate that Rhamnolipids are effective as surfactants for contact lenses OR as an antiviral/microbial for eyecare. Parity or superior in preservation of contact lens storage solution Vs. Onamer M; Mildness: parity or superior Vs. Onamer M.